Multicellular living organisms and unmodified parts thereof and – Nonhuman animal – Transgenic nonhuman animal
Reexamination Certificate
2001-11-14
2008-08-19
Chen, Shin-Lin (Department: 1632)
Multicellular living organisms and unmodified parts thereof and
Nonhuman animal
Transgenic nonhuman animal
C800S013000, C800S014000
Reexamination Certificate
active
07414171
ABSTRACT:
The invention relates to BALB/c mice that are deficient in the programmed cell death-1 receptor (PD-1), a screening method for autoimmune disease medicine using these mice, an IgG self-reactive antibody that the mice produce, a protein that specifically reacts to the antibody and is produced in heart, and a diagnostic method for dilated cardiomyopathy using the protein. Because PD-1 deficient BALB/c mice spontaneously develop autoimmune disease, and specifically dilated cardiomyopathy, they are useful for screening for medicines against these diseases.
REFERENCES:
patent: 5629204 (1997-05-01), Honjo et al.
Nishimura et al., 1998, International Immunology, vol. 10, No. 10, pp. 1563-1572.
Mogil et al., 1999, Pain, vol. 80, pp. 67-82.
Sigmund, C., Jun. 2000, Arterioscler. Thromb. Vasc. Biol., p. 1425-1429.
Wither et al., 1998, Journal of Immunology, vol. 161, p. 4555-4562.
Leonard et al., 1995, Immunological Reviews, vol. 148, pp. 97-114.
Rescher et al., 2004, Journal of Cell Science, vol. 117, p. 2631-2639.
Nishimura, H. et al., Science, vol. 291, pp. 319 to 322, (2001).
Nishimura, H. et al., Immunity, vol. 11, pp. 141 to 151, (1999).
Nishimura, H. et al., J. Exp. Med., vol. 191 (5), pp. 891-897.
Nishimura., H. et al., International Immunology, vol. 10 (10), pp. 1563 to 1572, (1998).
Freeman, G. et al., J. Exp. Med., vol. 192 (7), pp. 1027 to 1034, (Oct. 2000).
Fazekas, G., et al., “Isolation and characterization of IGG-2A-reactive autoantibodies from influenza virus-infected BALB-C mice”, European Journal of Immunology, vol. 20, No. 12, 1990, pp. 2719-2730.
Satoh, M., et al., “Pristane induces high titers of anti-Su and anti-nRNP/Sm autoantibodies in BALB/c mice Quantitation by antigen capture ELISAs based on monospecific human autoimmune sera,” Journal of Immunological Methods, Elisevier Science Publishers B.V., Amsterdam, NL, vol. 182, No. 1, May 11, 1995.
Bhavsar P.K., et al., “Isolation and characterization of the human cardiac troponin I gene (TNN13)”, Genomics, Academic Press, San Diego, US, vol. 35, No. 1, 1996, pp. 11-23.
Crimando J., et al., “Characterization of murine brain-reactive monoclonal IgG autoantibodies,” Brain Behavior and Immunity, vol. 9, No. 3, 1995, pp. 165-181.
Okazaki, Taku, et al., “Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice,” Nature Medicine, Nature Publishing Group, New York, NY, US, vol. 9, No. 12, Dec. 2003, pp. 1477-1483.
Supplementary European Search Report dated Jun. 12, 2007, p. 1.
Luppi, Patrizia, et al., “Idiopathic Dilated Cardiomyopathy, A superantigen-driven autoimmune disease”, Circulation, 1998, vol. 98, pp. 777-785.
Korean Office Action.
Honjo Tasuku
Nishimura Hiroyuki
Chen Shin-Lin
Honjo Tasuku
Ono Pharmaceutical Co. Ltd.
Sughrue & Mion, PLLC
LandOfFree
PD-1-lacking mouse and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PD-1-lacking mouse and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PD-1-lacking mouse and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4000987